Takeda Pharmaceutical
$17.86Change from previous close: −1.81%Absolute change: −$0.33
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $57.06B
- Enterprise value
- $5.13T
- Forward P/E
- 33.7
- PEG
- 0.41
- Price/book
- 1.18
- Price/sales
- 0.01
- EV/EBITDA
- 4.11
- EV/revenue
- 1.11
Profitability and growth
- Gross margin
- 64.5%
- Operating margin
- 16.4%
- Net margin
- -3.5%
- ROE
- -2.3%
- ROA
- 2.7%
- Revenue growth (year over year)
- 10.2%
- Earnings growth (year over year)
- -9.8%
Financial health
- Total cash
- $460.98B
- Total debt
- $5.54T
- Debt/equity
- 0.73
- Current ratio
- 1.14
- Quick ratio
- 0.51
Dividends
- Annual dividend per share
- $0.62
- Dividend yield
- 3.5%
- Payout ratio
- 80.0%
- Ex-dividend date
- March 31, 2026
Analysts and estimates
- Average price target
- $22.01
- Median price target
- $22.11
- High price target
- $22.96
- Low price target
- $20.97
- Analysts with a price target
- 3
- Consensus
- Strong buy
- Forward EPS
- $0.53
- EPS estimate, current year
- $149.59
Shares and trading
- Beta
- 0.10
- Average volume
- 3.01M
- Shares outstanding
- 3.19B
- Float
- 3.16B
- Institutional ownership
- 3.3%
- Insider ownership
- 0.1%
- Short interest (% of float)
- 0.1%
- Short ratio (days)
- 1.92